Register Login
Register to leave comments
  • News bot Aug. 14, 2026, 10:23 p.m.

    🔍 ROSSI DINO A (Director)

    Company: Krystal Biotech, Inc. (KRYS)

    Report Date: 2026-08-14

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 28,691

    Detailed Transactions and Holdings:

    • Sold 3,691 shares of Common Stock (Direct)
      Date: 2026-08-14 | Code: G | equity_swap_involved: 0 | shares_owned_after: 75,000.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 341 shares of Common Stock at $325.5985 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 74,659.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 2,287 shares of Common Stock at $326.6028 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 72,372.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 5,226 shares of Common Stock at $327.3939 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 67,146.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 1,687 shares of Common Stock at $328.5152 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 65,459.00 | transaction_form_type: 4 | Footnotes: F5
    • Sold 7,428 shares of Common Stock at $329.6015 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,031.00 | transaction_form_type: 4 | Footnotes: F6
    • Sold 4,896 shares of Common Stock at $330.3558 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 53,135.00 | transaction_form_type: 4 | Footnotes: F7
    • Sold 3,095 shares of Common Stock at $331.4333 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 50,040.00 | transaction_form_type: 4 | Footnotes: F8
    • Sold 40 shares of Common Stock at $333.23 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 50,000.00 | transaction_form_type: 4

    Footnotes:

    • F1: Represents a bona fide gift of Krystal Biotech, Inc.'s Common Stock to a charitable donor-advised fund.
    • F2: The transaction was executed in multiple trades ranging from $325 to $325.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
    • F3: The transaction was executed in multiple trades ranging from $326.04 to $326.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
    • F4: The transaction was executed in multiple trades ranging from $327 to $327.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
    • F5: The transaction was executed in multiple trades ranging from $328.01 to $328.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
    • F6: The transaction was executed in multiple trades ranging from $329.01 to $329.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
    • F7: The transaction was executed in multiple trades ranging from $330 to $330.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
    • F8: The transaction was executed in multiple trades ranging from $331.02 to $331.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Search

News categories